Skip to main content
Watch Insiders
PBYIHealthcare

Puma Biotechnology Inc (PBYI) Insider Trading

In the last 90 days, 2 Puma Biotechnology Inc (PBYI) insiders reported no open-market purchases and 2 sales totaling $612,494. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 14, 2026Troy Edward WilsonCorporate insiderSale5,000$9.10$45,500
Sep 14, 2026Alessandra CesanoCorporate insiderSale62,150$9.12$566,994
Jul 6, 2026Alan H AuerbachPresident and CEOSale44,058$8.26$364,051
Jul 6, 2026Douglas M HuntSee RemarksSale8,460$8.26$69,905
Jul 6, 2026Maximo F NouguesChief Financial OfficerSale9,386$8.26$77,557
Jun 12, 2026Troy Edward WilsonCorporate insiderSale10,800$7.20$77,748
Jun 12, 2026Brian M StuglikCorporate insiderSale8,100$7.20$58,311
Jun 12, 2026Adrian SenderowiczCorporate insiderSale27,000$7.20$194,311
Jun 12, 2026Jay M MoyesCorporate insiderSale22,000$7.22$158,796
Jun 12, 2026Allison DorvalCorporate insiderSale11,610$7.20$83,579

Common questions

PBYI insider trading FAQ

Are PBYI insiders buying or selling?
Over the last 90 days, PBYI insiders were net sellers, reporting $0.00 of open-market purchases and $612,494 of sales.
When was the last PBYI insider purchase?
No open-market insider purchase of Puma Biotechnology Inc stock was reported in the last 90 days.
Where does PBYI insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Puma Biotechnology Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.